Improved Automatic Diabetic Retinopathy Severity Classification Using Deep Multimodal Fusion of UWF-CFP and OCTA Images

Diabetic Retinopathy (DR), a prevalent and severe complication of diabetes, affects millions of individuals globally, underscoring the need for accurate and timely diagnosis. Recent advancements in imaging technologies, such as Ultra-WideField Color Fundus Photography (UWF-CFP) imaging and Optical Coherence Tomography Angiography (OCTA), provide opportunities for the early detection of DR but also pose significant challenges given the disparate nature of the data they produce. This study introduces a novel multimodal approach that leverages these imaging modalities to notably enhance DR classification. Our approach integrates 2D UWF-CFP images and 3D high-resolution 6x6 mm$^3$ OCTA (both structure and flow) images using a fusion of ResNet50 and 3D-ResNet50 models, with Squeeze-and-Excitation (SE) blocks to amplify relevant features. Additionally, to increase the model's generalization capabilities, a multimodal extension of Manifold Mixup, applied to concatenated multimodal features, is implemented. Experimental results demonstrate a remarkable enhancement in DR classification performance with the proposed multimodal approach compared to methods relying on a single modality only. The methodology laid out in this work holds substantial promise for facilitating more accurate, early detection of DR, potentially improving clinical outcomes for patients.

Multimodal Information Fusion For The Diagnosis Of Diabetic Retinopathy

Diabetes is a chronic disease characterized by excess sugar in the blood and affects 422 million people worldwide, including 3.3 million in France. One of the frequent complications of diabetes is diabetic retinopathy (DR): it is the leading cause of blindness in the working population of developed countries. As a result, ophthalmology is on the verge of a revolution in screening, diagnosing, and managing of pathologies. This upheaval is led by the arrival of technologies based on artificial intelligence. The "Evaluation intelligente de la r\'etinopathie diab\'etique" (EviRed) project uses artificial intelligence to answer a medical need: replacing the current classification of diabetic retinopathy which is mainly based on outdated fundus photography and providing an insufficient prediction precision. EviRed exploits modern fundus imaging devices and artificial intelligence to properly integrate the vast amount of data they provide with other available medical data of the patient. The goal is to improve diagnosis and prediction and help ophthalmologists to make better decisions during diabetic retinopathy follow-up. In this study, we investigate the fusion of different modalities acquired simultaneously with a PLEXElite 9000 (Carl Zeiss Meditec Inc. Dublin, California, USA), namely 3-D structural optical coherence tomography (OCT), 3-D OCT angiography (OCTA) and 2-D Line Scanning Ophthalmoscope (LSO), for the automatic detection of proliferative DR.

Multimodal Information Fusion for Glaucoma and DR Classification

Multimodal information is frequently available in medical tasks. By combining information from multiple sources, clinicians are able to make more accurate judgments. In recent years, multiple imaging techniques have been used in clinical practice for retinal analysis: 2D fundus photographs, 3D optical coherence tomography (OCT) and 3D OCT angiography, etc. Our paper investigates three multimodal information fusion strategies based on deep learning to solve retinal analysis tasks: early fusion, intermediate fusion, and hierarchical fusion. The commonly used early and intermediate fusions are simple but do not fully exploit the complementary information between modalities. We developed a hierarchical fusion approach that focuses on combining features across multiple dimensions of the network, as well as exploring the correlation between modalities. These approaches were applied to glaucoma and diabetic retinopathy classification, using the public GAMMA dataset (fundus photographs and OCT) and a private dataset of PlexElite 9000 (Carl Zeis Meditec Inc.) OCT angiography acquisitions, respectively. Our hierarchical fusion method performed the best in both cases and paved the way for better clinical diagnosis.